ExGen Dx
PrivateLast Round
Grant
Jun 9, 2025
Total Funding Raised
$1.75M
Company Overview
ExGen Dx operates in Healthcare & Life Sciences and is based in Birmingham. Its latest recorded funding round was a Grant round in June 2025.
ExGen Dx is a biotechnology company that develops rapid, point-of-care diagnostic tests for infectious diseases, particularly sexually transmitted infections, using its proprietary EXPAR and linear dichroism technologies.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Sensors
Business Model
B2B
Customer Profile
Usage-Based SaaS, Hardware Sales, Government Contracts, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ExGen Dx Comparables
Compare ExGen Dx with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Rapidemic | 86% | |
| binx health | 81% | |
| Visby Medical | 78% |
For institutional investors. Book with your work email.
ExGen Dx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 9, 2025 | ||||
| VC Round | Feb 24, 2021 | ||||
| VC Round | Nov 14, 2019 | ||||
| Seed | May 24, 2017 |
For institutional investors. Book with your work email.
ExGen Dx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Future Planet Capital Regional | VC Round |
| Midven | VC Round |
| British Business Bank | VC Round |
| UK Innovation & Science Seed Fund | Seed, VC Round |
| National Institute for Health and Care Research | Grant |
| University of Birmingham Enterprise | Seed |
| University of Birmingham | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 12, 2026
Monthly visitors increased 517% MoM, reaching 1.1K.
- Jun 9, 2025
$1.36M grant from the National Institute for Health and Care Research.
For institutional investors. Book with your work email.
ExGen Dx Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about ExGen Dx's valuation, stock price, and market status.
Is ExGen Dx a public or private company?
ExGen Dx is a private company.
What is the current stock price of ExGen Dx?
ExGen Dx is a private company, so its shares have no public market price. Caplight tracks ExGen Dx's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ExGen Dx worth (valuation)?
Valuation information for ExGen Dx is not publicly available.
Can I buy ExGen Dx stock?
ExGen Dx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ExGen Dx's last funding round?
ExGen Dx's most recent funding round was Grant on June 9, 2025.
Who are the main investors in ExGen Dx?
Key investors in ExGen Dx include Midven.
Will ExGen Dx IPO soon?
No public IPO plans have been announced for ExGen Dx.
How can I track ExGen Dx secondary market activity?
Caplight tracks bids, offers, and trades in ExGen Dx's shares on secondary markets.